Magnesium Pantoprazole 20 mg
MX026
Phase 3 small_molecule terminated
Quick answer
Magnesium Pantoprazole 20 mg for Gastric pH Control is a Phase 3 program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Gastric pH Control
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated